You might also like
CONMED Corporation (CNMD) is a global medical technology company that develops, manufactures, and sells devices and equipment for surgical procedures. Its products are used by surgeons and healthcare professionals across various specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. The company focuses on single-use products and accessories for capital equipment, generating recurring revenue streams, and operates in both domestic and international markets.
- General Surgery - Offers endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, cardiac monitoring products, electrosurgical generators, and related instruments.
- Orthopedic Surgery - Includes sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments, imaging systems for minimally invasive surgical procedures, and service fees related to the promotion and marketing of sports medicine allograft tissue.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Patrick J. Beyer ExecutiveBoard | President and Chief Executive Officer (CEO) | Board Member at Bioventus (Audit Committee) | Joined CNMD in 2014 as President of CONMED International; became CEO on January 1, 2025. Previously held leadership roles at Stryker and ICNet. | View Report → |
Brent Lalomia Executive | Vice President, Quality Assurance, Regulatory Affairs, Customer Experience, and Logistics | None | Joined CNMD in 2017. Promoted to current role in May 2023. Previously held leadership roles at Stryker. | |
Edward Clifford Executive | Vice President, Global Manufacturing | None | Joined CNMD in July 2023. Previously held leadership roles at Consumers Energy, Stryker, and Eaton. Holds a degree in Mechanical Engineering. | |
John Ferrell Executive | Executive Vice President, Human Resources | Board Member at LECMPA | Joined CNMD in 2015 as VP, Human Resources, International. Promoted to EVP, Human Resources in December 2022. Holds degrees in Psychology and Labor Relations. | |
Johonna Pelletier Executive | Treasurer and Vice President, Tax | None | Joined CNMD in 2005 as Tax Director. Promoted to current role in 2015. Previously worked at PricewaterhouseCoopers LLP. Certified Public Accountant. | |
Kimberly A. Lockwood Executive | Interim Corporate Controller | None | Joined CNMD in 2005 as Director of Financial Reporting & Controls. Assumed interim role on September 30, 2024, after Eric B. Staves' departure. Certified Public Accountant. | |
Peter K. Shagory Executive | Executive Vice President, Strategy and Corporate Development | None | Joined CNMD in 2015. Previously led strategy and business development at Cardinal Health and held leadership roles in venture capital and investment banking. | |
Todd W. Garner Executive | Executive Vice President, Finance and CFO | None | Joined CNMD in 2018 as CFO. Previously held financial leadership roles at C.R. Bard, Echopass, and Verizon. Certified Public Accountant. | |
Barbara J. Schwarzentraub Board | Director | None | Director since 2019. Chair of the Audit Committee. Recognized as an audit committee financial expert. | |
Charles M. Farkas Board | Director | Advisory Partner at Bain & Company; Chair of Medicinal Genomics; Board Member at United Bridge Partners and John A. Hartford Foundation | Director since 2014. Former Global Co-Head of Bain's Healthcare Practice. Extensive experience in healthcare and medical technology. | |
John L. Workman Board | Director | Chair of the Board at Agiliti, Inc.; Director at Federal Signal Corporation | Director since 2015. Extensive financial and accounting experience. Recognized as an audit committee financial expert. | |
LaVerne Council Board | Director | Board Member at Concentrix, Thomson Reuters, Mathematica, Girl Up, and March of Dimes | Director since 2019. CEO of Emerald One, LLC. Extensive experience in IT and digital transformation. Holds an MBA from Illinois State University. | |
Martha Goldberg Aronson Board | Lead Independent Director | None | Director since 2016. Extensive experience in global healthcare businesses. Former interim CEO of Beta Bionics. Holds an MBA from Harvard Business School. |
-
Given that supply chain challenges in your Orthopedics business have persisted longer than expected and have hindered growth, what specific measures are you implementing with the top-tier consulting firm to turn operations from a weakness into a strength, and what is the expected timeline for seeing tangible improvements?
-
Your revenue guidance for 2025 is 4% to 6% growth, which is at the low end of your midterm potential of 4% to 9%; considering you just grew 5.3% in 2024 and expressed disappointment in that performance, what are the key factors limiting higher guidance, and how confident are you in your ability to accelerate growth in the coming years?
-
With gross margins facing headwinds from currency impacts and operational inefficiencies, how do you plan to offset these challenges to improve profitability, and when do you expect to realize the benefits of your mix tailwinds and operational improvements?
-
Considering your focus on reducing leverage below 3 and your comment that M&A activity would only proceed if there is a "really compelling asset," how should we think about your capital allocation priorities in 2025 and beyond?
-
As you conduct a deep dive into your 55-year-old portfolio with the goal of improving durability, growth, and profitability, are there specific areas where you anticipate divesting or making significant changes, and how will this review impact your strategic focus moving forward?
Competitors mentioned in the company's latest 10K filing.
| Company | Description |
|---|---|
Competes in the orthopedic surgery market, offering products that address sports medicine injuries and soft tissue repair, similar to the company's offerings such as BioBrace®, TruShot® with Y-Knot® All-In-One Soft Tissue Fixation System, and others. | |
Arthrex, Inc. | Operates in the orthopedic surgery market, providing solutions for sports medicine injuries and soft tissue repair, competing with the company's portfolio of implants and supporting products. |
Competes in both orthopedic surgery and powered instruments markets, offering a range of products that overlap with the company's surgical tools and implants. | |
Johnson & Johnson: DePuy Mitek, Inc. | A competitor in the orthopedic surgery market, focusing on sports medicine and soft tissue repair solutions. |
Zimmer Biomet, Inc. | Competes in the orthopedic surgery market, providing implants and surgical tools similar to the company's offerings. |
Operates in the extremity market, competing with the company's foot and ankle surgery products like the Quantum® Total Ankle System. | |
Competes in the extremity market, offering solutions for foot and ankle surgeries, similar to the company's CoLink® plating system. | |
A competitor in the powered instruments market, providing surgical tools that overlap with the company's Hall® surgical brand. | |
Johnson & Johnson: DePuy Synthes, Inc. | Competes in the powered instruments market, offering products for orthopedic and other surgeries. |
Competes in the general surgery market, offering advanced surgical and endoscopic technologies that overlap with the company's AirSeal® insufflation system and smoke evacuation products. | |
Johnson & Johnson: Ethicon Endo-Surgery, Inc. | A competitor in the general surgery market, providing endomechanical and electrosurgical products similar to the company's offerings. |
Stryker Endoscopy | Competes in the general surgery market, offering endoscopic technologies that overlap with the company's product lines. |
Olympus Corporation | Operates in the general surgery market, providing endoscopic and surgical products that compete with the company's advanced technologies. |
ERBE Elektromedizin GmbH | A competitor in the general surgery market, offering electrosurgical products similar to the company's portfolio. |
Applied Medical Resources Corporation | Competes in the general surgery market, providing surgical instruments and technologies that overlap with the company's offerings. |
Competes in the advanced endoscopic technologies market, offering therapeutic and diagnostic products for gastroenterology procedures. | |
Cook Medical, Inc. | A competitor in the advanced endoscopic technologies market, providing products for gastroenterology and related procedures. |
Merit Medical Endotek | Competes in the advanced endoscopic technologies market, offering solutions for gastroenterology procedures. |
Olympus Corporation | Operates in the advanced endoscopic technologies market, providing diagnostic and therapeutic products for gastroenterology. |
STERIS Corporation - U.S. Endoscopy | A competitor in the advanced endoscopic technologies market, offering products for gastroenterology and infection prevention. |
Cantel Medical- Medivators, Inc. | Competes in the advanced endoscopic technologies market, providing infection prevention and therapeutic products. |
A competitor in the advanced endoscopic technologies market, offering a range of products for gastroenterology procedures. | |
Operates in the advanced endoscopic technologies market, providing products for infection prevention and patient monitoring. |
No recent press releases or 8-K filings found for CNMD.